Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Deerfield Management Company

Latest statistics and disclosures from Deerfield Management Company's latest quarterly 13F-HR filing:

Top 5 stock holdings are NUVL, Brookdale Sr Living, COGT, PRAX, VTRS, and represent 37.80% of Deerfield Management Company's stock portfolio.
Added to shares of these 10 stocks: Arrowhead Pharmaceuticals In Note 1/1 (+$207M), INDV (+$94M), SNDX (+$88M), DNTH (+$86M), PFE (+$85M), Zenas Biopharma (+$67M), GMAB (+$66M), XENE (+$62M), INSP (+$62M), BMRN (+$48M).
Started 12 new stock positions in DNTH, Zenas Biopharma, INDV, DRUG, SNDX, Arrowhead Pharmaceuticals In Note 1/1, BMRN, GMAB, Veradermics, PFE. Spyglass Pharma, TYRA.
Reduced shares in these 10 stocks: Indivior (-$122M), NBIX (-$76M), RVMD (-$58M), PHR (-$34M), MRNA (-$30M), Lantheus Hldgs Inc Note 2.62512/1 (-$29M), VTR (-$27M), CPRX (-$24M), SYRE (-$23M), IDYA (-$21M).
Sold out of its positions in ABT, ABBV, ABEO, ADUS, SYRE, ALGN, ALHC, ATEC, AMPH, ARVN.
Deerfield Management Company was a net buyer of stock by $420M.
Deerfield Management Company has $8.5B in assets under management (AUM), dropping by 8.25%.
Central Index Key (CIK): 0001009258

Tip: Access up to 7 years of quarterly data

Positions held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Deerfield Management Company

Deerfield Management Company holds 82 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Nuvalent Inc-a (NUVL)	20.8	$1.8B		17M	102.45	View chart
Brookdale Sr Living Note 3.500%10/1 (Principal)	6.0	$505M		307M	1.65	View chart
Cogent Biosciences (COGT)	4.1	$348M		9.0M	38.49	View chart
Praxis Precision Medicines I Com New (PRAX)	3.7	$310M	+6%	963k	322.19	View chart
Viatris (VTRS)	3.2	$273M		20M	13.51	View chart
United Therapeutics Corporation (UTHR)	3.2	$271M	+7%	457k	592.98	View chart
Revolution Medicines (RVMD)	2.6	$223M	-20%	2.3M	97.25	View chart
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)	2.5	$209M		70M	2.99	View chart
Arrowhead Pharmaceuticals In Note 1/1 (Principal)	2.4	$207M	NEW	200M	1.04	View chart
Celcuity (CELC)	2.3	$196M		1.7M	114.14	View chart
Centene Corporation (CNC)	2.3	$194M	-8%	5.9M	32.74	View chart
Larimar Therapeutics (LRMR)	1.9	$160M	+16%	36M	4.50	View chart
Brookdale Senior Living (BKD)	1.9	$159M		12M	13.68	View chart
Vera Therapeutics Cl A (VERA)	1.8	$150M	-8%	3.7M	40.23	View chart
Ionis Pharmaceuticals (IONS)	1.8	$149M		2.0M	75.09	View chart
BioCryst Pharmaceuticals (BCRX)	1.7	$143M	+4%	15M	9.52	View chart
Inspire Med Sys (INSP)	1.6	$139M	+79%	2.7M	51.58	View chart
Legend Biotech Corp Sponsored Ads (LEGN)	1.6	$139M	+29%	7.7M	18.09	View chart
Adapthealth Corp Common Stock (AHCO)	1.6	$137M		12M	11.90	View chart
Newamsterdam Pharma Company Ordinary Shares (NAMS)	1.6	$137M	+2%	4.3M	32.01	View chart
Acadia Healthcare (ACHC)	1.2	$106M		4.5M	23.39	View chart
Arrowhead Pharmaceuticals (ARWR)	1.2	$99M	-14%	1.6M	62.70	View chart
Catalyst Pharmaceutical Partners (CPRX)	1.2	$98M	-19%	3.9M	24.76	View chart
Indivior Pharmaceuticals (INDV)	1.1	$94M	NEW	3.1M	30.48	View chart
Xenon Pharmaceuticals (XENE)	1.1	$94M	+198%	1.6M	58.15	View chart
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)	1.1	$91M		60M	1.51	View chart
Pharvaris N V (PHVS)	1.0	$88M		3.1M	28.25	View chart
Syndax Pharmaceuticals (SNDX)	1.0	$88M	NEW	3.8M	23.36	View chart
Tango Therapeutics (TNGX)	1.0	$87M	+42%	4.1M	20.92	View chart
Alignment Healthcare Note 4.250%11/1 (Principal)	1.0	$86M		61M	1.41	View chart
Dianthus Therapeutics (DNTH)	1.0	$86M	NEW	1.0M	83.92	View chart
Pfizer (PFE)	1.0	$85M	NEW	3.0M	28.08	View chart
Neurocrine Biosciences (NBIX)	0.9	$80M	-48%	610k	131.74	View chart
Day One Biopharmaceuticals I (DAWN)	0.9	$80M		3.7M	21.44	View chart
Savara (SVRA)	0.9	$74M		14M	5.46	View chart
Zenas Biopharma Note 2.500% 4/0 (Principal)	0.8	$67M	NEW	65M	1.03	View chart
Enhabit Ord (EHAB)	0.8	$67M		4.7M	14.09	View chart
Neogenomics Note 0.250% 1/1 (Principal)	0.8	$67M		73M	0.92	View chart
Genmab A/s Sponsored Ads (GMAB)	0.8	$66M	NEW	2.5M	26.83	View chart
Bio Rad Labs Cl A (BIO)	0.7	$63M		226k	278.75	View chart
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)	0.7	$63M		828k	75.85	View chart
Silverback Therapeutics (SPRY)	0.7	$60M		7.5M	8.03	View chart
Stoke Therapeutics (STOK)	0.7	$59M		1.8M	32.56	View chart
Envista Hldgs Corp (NVST)	0.7	$56M	-3%	2.2M	25.37	View chart
Ideaya Biosciences (IDYA)	0.6	$51M	-28%	1.5M	33.32	View chart
Belite Bio Sponsored Ads (BLTE)	0.6	$49M	+30%	304k	159.44	View chart
BioMarin Pharmaceutical (BMRN)	0.6	$48M	NEW	852k	56.49	View chart
Kymera Therapeutics (KYMR)	0.6	$47M		561k	83.29	View chart
Certara Ord (CERT)	0.5	$45M		7.8M	5.70	View chart
Bridgebio Oncology Therapeut Com New (BBOT)	0.5	$44M		4.9M	8.95	View chart
Disc Medicine (IRON)	0.5	$42M	+28%	657k	63.94	View chart
Livanova Note 2.500% 3/1 (Principal)	0.5	$40M		34M	1.17	View chart
Sionna Therapeutics (SION)	0.5	$39M		971k	40.09	View chart
Caredx (CDNA)	0.4	$38M		2.2M	17.36	View chart
Structure Therapeutics Sponsored Ads (GPCR)	0.4	$37M		768k	48.20	View chart
Immunocore Hldgs Note 2.500% 2/0 (Principal)	0.3	$27M		30M	0.90	View chart
Veracyte (VCYT)	0.3	$23M		726k	32.21	View chart
Alnylam Pharmaceuticals (ALNY)	0.3	$23M		68k	330.87	View chart
Embecta Corp Common Stock (EMBC)	0.3	$22M	-7%	2.5M	8.84	View chart
Tyra Biosciences (TYRA)	0.2	$21M	NEW	549k	38.30	View chart
Foghorn Therapeutics (FHTX)	0.2	$21M	+20%	4.4M	4.78	View chart
Bright Minds Biosciences Com New (DRUG)	0.2	$21M	NEW	283k	72.97	View chart
Compass Therapeutics (CMPX)	0.2	$19M		3.6M	5.29	View chart
Monopar Therapeutics Com New (MNPR)	0.2	$18M	+89%	324k	54.79	View chart
Kyverna Therapeutics (KYTX)	0.2	$17M		2.0M	8.63	View chart
Spyglass Pharma Com Shs	0.2	$14M	NEW	550k	25.91	View chart
Beta Bionics (BBNX)	0.2	$13M	+41%	1.3M	10.02	View chart
Taysha Gene Therapies Com Shs (TSHA)	0.1	$12M		2.7M	4.47	View chart
Oncology Institu (TOI)	0.1	$10M		3.4M	3.07	View chart
Cullinan Oncology (CGEM)	0.1	$5.5M		386k	14.21	View chart
Annexon (ANNX)	0.0	$3.2M		584k	5.54	View chart
Alector (ALEC)	0.0	$2.3M		1.1M	2.15	View chart
Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW)	0.0	$1.9M		93k	20.04	View chart
Edwards Lifesciences (EW)	0.0	$1.1M		14k	80.08	View chart
Biomx Com New (PHGE)	0.0	$493k		131k	3.75	View chart
Veradermics Common Stock	0.0	$316k	NEW	5.0k	63.15	View chart
Humana (HUM)	0.0	$159k		917.00	173.39	View chart
The Oncology Institute *w Exp 99/99/999 (TOIIW)	0.0	$55k		1.3M	0.04	View chart
Quantum Si *w Exp 06/10/202 (QSIAW)	0.0	$36k		333k	0.11	View chart
Pmv Pharmaceuticals (PMVP)	0.0	$11k		8.8k	1.24	View chart
Surrozen *w Exp 08/01/203 (SRZNW)	0.0	$2.7k		167k	0.02	View chart
Myriad Genetics (MYGN)	0.0	$2.3k		505.00	4.50	View chart

Past Filings by Deerfield Management Company

SEC 13F filings are viewable for Deerfield Management Company going back to 2010

Deerfield Management Company 2026 Q1 filed May 15, 2026
Deerfield Management Company 2025 Q4 filed Feb. 17, 2026
Deerfield Management Company 2025 Q3 filed Nov. 14, 2025
Deerfield Management Company 2025 Q2 filed Aug. 14, 2025
Deerfield Management Company 2025 Q1 filed May 15, 2025
Deerfield Management Company 2024 Q4 filed Feb. 14, 2025
Deerfield Management Company 2024 Q3 filed Nov. 14, 2024
Deerfield Management Company 2024 Q2 filed Aug. 14, 2024
Deerfield Management Company 2024 Q1 filed May 15, 2024
Deerfield Management Company 2023 Q4 filed Feb. 14, 2024
Deerfield Management Company 2023 Q3 filed Nov. 14, 2023
Deerfield Management Company 2023 Q2 filed Aug. 14, 2023
Deerfield Management Company 2023 Q1 filed May 15, 2023
Deerfield Management Company 2022 Q4 filed Feb. 14, 2023
Deerfield Management Company 2022 Q3 filed Nov. 14, 2022
Deerfield Management Company 2022 Q2 filed Aug. 15, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z